A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Pancreatic Ductal Adenocarcinoma · Non Small Cell Lung Cancer · Colorectal Cancer · Solid Tumor, Adult · G12D Mutated KRAS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Study coordinator (Shannon Cyhan) · shannon.cyhan@cshs.org
Contact: Principal Investigator (Arsen Osipov, MD)
Johns Hopkins University, Baltimore, Maryland, United States
Contact: Study coordinator (Nilofer Azad) · nilo.azad@jhu.edu · 410-614-3644
Contact: Principal Investigator (Nilofer Azad, MD)
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Leon Pappas, MD) · lpappas3@mgb.org · 617-724-4000
Contact: Principal Investigator (Leon Pappas, MD)
University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Vaibhav Sahai, MD) · CancerAnswerLine@med.umich.edu · 800-865-1125
Contact: Principal Investigator (Vaibhav Sahai, MBBS, MS)
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Study coordinator (Sara Mitchum) · saram@wustl.edu · 314-273-8602
Contact: Principal Investigator (Kian-Huat Lim, MD)
Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
Contact: Study coordinator (Jennifer Coffey) · DL_Phase1Screening@nyulangone.org
Contact: Principal Investigator (Kristen Spencer, DO)
Univ of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Mark O'Hara, MD) · Mark.OHara@pennmedicine.upenn.edu · 215-360-0919
Contact: Principal Investigator (Mark O'Hara, MD)
SCRI Oncology Partners, Nashville, Tennessee, United States
Contact: Study coordinator (SCRI Referral Team) · SCRI.DDUreferrals@scri.com · 615-341-7844
Contact: Principal Investigator (Melissa Johnson, MD)
MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Ly M Nguyen) · lmnguyen1@mdanderson.org · 832-794-3672
Contact: Principal Investigator (David Hong, MD)
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Contact: Study coordinator (Susan Sharry) · susan.sharry@hci.utah.edu · 801-585-3453
Contact: Principal Investigator (Matthew Gumbleton, MD)
University of Virginia, Charlottesville, Virginia, United States
Contact: Study coordinator (Polly Wu) · rw6aq@uvahealth.org · 434-924-9286
Contact: Principal Investigator (Matthew Reilley, MD)
Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact: Study coordinator (Carrie Friedman, RN, BSN, OCN) · carrie.friedman@usoncology.com · 703-636-1473
Contact: Principal Investigator (Alexander Spira, MD)
Virginia Mason Medical Center, Seattle, Washington, United States
Contact: Study coordinator (Colleen Soleau) · colleen.soleau@commonspirit.org · 206-287-6272
Contact: Principal Investigator (Vincent Picozzi, MD)
Peninsula and Southeast Oncology, Frankston, Victoria, Australia
Contact: Study coordinator (Albert Goikhman) · ag@paso.com.au · 61 3 9781 5244
Contact: Principal Investigator (Vinod Ganju, MBBS)

View source on ClinicalTrials.gov Contact study team (email)